Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Maintenance Therapy in HER2+ Metastatic Breast Cancer (MBC)Release Date:Education Oncology USA Efforts to Improve Quality of Migraine CareRelease Date:Partner: The Japanese Headache SocietyQuality Improvement Internal Medicine Japan Enhancing HCP Education in Adult Vaccination against Respiratory InfectionsRelease Date:Education Vaccines Austria, Belgium, Greece, Ireland, Luxembourg, Portugal, Switzerland Migraine and Women’s HealthQuality Improvement, Research Internal Medicine USA Improving Health Outcomes in Patients with ATTR-CM Through the Development of a Shared Decision-Making Tool (Decision Aid)Release Date:Research Rare Disease USA Real World Evidence on clinical outcomes with Aztreonam-Avibactam (ATM-AVI)Release Date:Research Inflammation & Immunology All Capacity Building for Clinical Trials in Sickle Cell Disease (SCD) - Education for Healthcare ProfessionalsRelease Date:Education Rare Disease USA Prostate Cancer: Best Practices for Combining Targeted Therapies in mPCRelease Date:Education Oncology USA Transthyretin Cardiac Amyloidosis FellowshipRelease Date:Research Rare Disease USA Optimizing Adult Vaccination Ecosystem in IndiaRelease Date:Quality Improvement Vaccines India Evidence Based Safety Contextualization of JAK inhibitors in the Treatment of Moderate to Severe Atopic DermatitisRelease Date:Education Inflammation & Immunology China, France, Germany, Italy, Japan, Korea, Spain, USA Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple MyelomaRelease Date:Research Oncology Spain Title Grant Type Focus Area Country Application Due Date Cardiac Transthyretin Amyloid (ATTR) FellowshipRelease Date:Partner: International Society of AmyloidosisFellowship Rare Disease All Early Diagnosis of Invasive Fungal Infections(Europe, Australia, New Zealand, Korea and Japan)Release Date:Research Hospital All Pfizer and RCNi – Providing Access to Learning Resources for Nurses in Emerging Markets AsiaEducation Support for the Professions Hong Kong, India, Indonesia, Malaysia, Pakistan, Philippines, Singapore, Taiwan, Thailand, Vietnam Optimizing Venous Thromboembolism Management in Latin AmericaRelease Date:Quality Improvement Internal Medicine All Improving Real-World Evidence & Data Generation Skills in Latin AmericaRelease Date:Education Support for the Professions All Alopecia Areata, Atopic Dermatitis and Vitiligo (Global)Release Date:Research Inflammation & Immunology All Relapsed/Refractory Multiple MyelomaRelease Date:Education Oncology USA Antimicrobial Stewardship (AMS) Programs to Address Health Inequities in Resource Limited SettingsRelease Date:Partner: Global Bridges at Mayo ClinicQuality Improvement Hospital All Increase HCP knowledge of Gene Therapy managementRelease Date:Education Rare Disease China Burden of Pneumococcal Disease - Analyzing Local Surveillance Data (Asia, Africa, Latin America, and Middle East)Release Date:Research Vaccines All Pre-clinical & Translational Research in Multiple MyelomaRelease Date:Research Oncology All Acute Lymphoblastic Leukemia Peer-to-Peer Education & SupportRelease Date:Education Oncology USA